Report #2828317

Received Feb 26, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Heart rate decreased

Symptom narrative

Low heart rate afterwards; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of heart rate low in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced heart rate low (Verbatim: Low heart rate afterwards). The outcome of the heart rate low was not reported. It was unknown if the reporter considered the heart rate low to be related to Shingrix. It was unknown if the company considered the heart rate low to be related to Shingrix. Additional Information: GSK Receipt Date: 21-FEB-2025 This case was reported by a patient via interactive digital media. The patient received Shingrix vaccine and had low hear rate afterwards.